Apple Q2 Results: Big Growth, But Why You Shouldn't Buy
Apple Inc. delivered another double beat in Q2, with revenues up 17% and EPS up 22% year-over-year.…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
1 signal unavailable — limited data for this stock
Trend
+23.4% vs SMA 50 · +29.0% vs SMA 200
Momentum
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2024 | $3.2B $3.1B–$3.2B | — | $3.38 | — | ±1% | High10 |
FY2025 | $3.3B $3.3B–$3.3B | ▲ +4.2% | $1.95 | ▼ -42.3% | ±1% | High10 |
FY2026(current) | $3.4B $3.4B–$3.5B | ▲ +3.7% | $1.47 | ▼ -24.4% | ±4% | High10 |
Apple Inc. delivered another double beat in Q2, with revenues up 17% and EPS up 22% year-over-year.…

acadia is a provider of inpatient and outpatient behavioral health and addiction treatment services. acadia operates a network of 225 behavioral healthcare facilities with approximately 9,190 beds in 37 states, the united kingdom and puerto rico. acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. acadia healthcare’s behavioral health treatment facilities are specialized solely in helping children, teenagers and adults suffering from mental health disorders and/or alcohol and drug addiction.